Measuring X inactivation skew for retinal diseases with adaptive nanopore sequencing
Preprint
Abstract
X-linked genetic disorders typically affect females less severely than males due to the presence of a second X chromosome not carrying the deleterious variant. However, the phenotypic expression in females is highly variable, which may be explained by an allelic skew in X chromosome inactivation. Accurate measurement of X inactivation skew is crucial to understand and predict disease phenotype in carrier females, with prediction especially relevant for degenerative conditions. We propose a novel approach using nanopore sequencing to quantify skewed X inactivation accurately. By phasing sequence variants and methylation patterns, this single assay reveals the disease variant, X inactivation skew, its directionality, and is applicable to all patients and X-linked variants. Enrichment of X-chromosome reads through adaptive sampling enhances cost-efficiency. Our study includes a cohort of 16 X-linked variant carrier females affected by two X-linked inherited retinal diseases: choroideremia and RPGR -associated retinitis pigmen-tosa. As retinal DNA cannot be readily obtained, we instead determine the skew from peripheral samples (blood, saliva and buccal mucosa), and correlate it to phenotypic outcomes. This revealed a strong correlation between X inactivation skew and disease presentation, confirming the value in performing this assay and its potential as a way to prioritise patients for early intervention, such as gene therapy currently in clinical trials for these conditions. Our method of assessing skewed X inactivation is applicable to all long-read genomic datasets, providing insights into disease risk and severity and aiding in the development of individualised strategies for X-linked variant carrier females.Keywords
All Related Versions
- Published version: Genome Research, 34 (11), 1954.
This publication has 43 references indexed in Scilit:
- Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapiesProgress in Retinal and Eye Research, 2023
- Long-Read Nanopore Sequencing of RPGR ORF15 is Enhanced Following DNase I Treatment of MinION Flow CellsMolecular Diagnosis & Therapy, 2023
- Nonrandom X Chromosome Inactivation DetectionCurrent Protocols, 2023
- X-chromosome inactivation patterns depend on age and tissue but not conception method in humansChromosome Research, 2023
- The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: A systematic reviewGenetics in Medicine, 2022
- X-Chromosome Inactivation Is a Biomarker of Clinical Severity in Female Carriers of RPGR-Associated X-Linked Retinitis PigmentosaOphthalmology Retina, 2019
- Comprehensive Rare Variant Analysis via Whole-Genome Sequencing to Determine the Molecular Pathology of Inherited Retinal DiseaseThe American Journal of Human Genetics, 2017
- The Role of X-Chromosome Inactivation in Retinal Development and Disease2015
- Correlation of Retinal Structure and Function in Choroideremia CarriersOphthalmology, 2015
- Age- and tissue-specific variation of X chromosome inactivation ratios in normal womenHuman Genetics, 2000